on a mobile?
 
vTap
    Loading...
 
 
Video
Andrew Jack, pharmaceuticals correspondent, on what the appointment of Andrew Witty means for GlaxoSmithKline
a year ago
Financial Times (FT.com)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
What The--?!
Go to Feed to see what's new!
share
keep
 
 
Jeremy Batstone of Charles Stanley Stockbrokers in London discusses the biggest rate cut in nearly 30 years
a week ago
RTE.ie
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris ...
6 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United States
Chief executive officer
United Kingdom
Pharmaceutical company
Mergers and acquisitions
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Food and Drug Administration
Chief executive officer
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Jeremy Batstone-Carr, an equity strategist at Charles Stanley, talks with Bloomberg's Mark Barton in London about the outlook for GlaxoSmithKline Plc's third-quarter earnings to be released today and its possible strategy under chief executive officer-designate Andrew Witty, who will succeed CEO Jean-Pierre Garnier in May. GlaxoSmithKline is Europe's largest drugmaker. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Chief executive officer
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use